Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma — Martin Kaiser (2020) | RDL Network
Martin Kaiser, Meral Beksaç, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek, Philippe Moreau, Felipe de Arriba, María‐Victoria Mateos, Sharon West, Andrew Spencer, S. Vincent Rajkumar, Kaveri Suryanarayan, Michael Czorniak, Cong Li, Zhaoyang Teng, Richard Labotka, Meletios A Dimopoulos
Martin Kaiser, Meral Beksaç, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek, Philippe Moreau, Felipe de Arriba, María‐Victoria Mateos, Sharon West, Andrew Spencer, S. Vincent Rajkumar, Kaveri Suryanarayan, Michael Czorniak, Zhaoyang Teng, Richard Labotka, Meletios A Dimopoulos
Fredrik Schjesvold, Hartmut Goldschmidt, Vladimír Maisnar, Ivan Špıčka, Neils Abildgaard, Philip Rowlings, Lauren E. Cain, Dorothy Romanus, Kaveri Suryanarayan, S. Vincent Rajkumar, Dawn Odom, Ari Gnanasakthy, Meletios A Dimopoulos
Meletios A Dimopoulos, Hartmut Goldschmidt, Vladimír Maisnar, Ivan Špıčka, Niels Abildgaard, Philip Rowlings, S. Vincent Rajkumar, Lauren E. Cain, Dorothy Romanus, Kaveri Suryanarayan, Dawn Odom, Ari Gnanasakthy, Fredrik Schjesvold
Fredrik Schjesvold, Hartmut Goldschmidt, Vladimír Maisnar, I Spicka, Niels Abildgaard, Philip Rowlings, Dawn Odom, Ari Gnanasakthy, Kaveri Suryanarayan, Lauren E. Cain, Dorothy Romanus, S. Vincent Rajkumar, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.